There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology.
As a NASDAQ listed company, RPID falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $1.13 and fluctuated between $1.4440 as its day high and $1.1200 as its day low. The current market capitalization of Rapid Micro Biosystems Inc. is $52.10M. A total of 0.38 million shares were traded on the day, compared to an average of 63.17K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, RPID has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 28 BUYs and 0 SELLs from insiders. Insiders purchased 656,366 shares during that period but sold 0.
In the most recent transaction, KENNEDY LEWIS MANAGEMENT LP bought 50,000 shares of RPID for 4.66 per share on Jun 03. After the transaction, the 10% Owner now owns 2,904,490 company shares. In a previous transaction on Jun 02, KENNEDY LEWIS MANAGEMENT LP bought 10,100 shares at 4.99 per share. RPID shares that 10% Owner owns now total 2,875,092.
Among the insiders who bought shares, KENNEDY LEWIS MANAGEMENT LP acquired of 47,117 shares on Jun 01 at a per-share price of $4.76. This resulted in the 10% Owner holding 2,869,154 shares of RPID after the transaction. In another insider transaction, KENNEDY LEWIS MANAGEMENT LP bought 20,000 shares at $5.11 per share on May 31. Company shares held by the 10% Owner now total 2,841,451.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for RPID in the last 3 months, the mean price target is $9.00 with high estimates of $9.00 and low estimates of $9.00. In terms of 52-week highs and lows, RPID has a high of $11.34 and a low of $1.20.
As of this writing, RPID has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.36 per share and a lower estimate of -$0.38. The company reported an EPS of -$0.35 in the last quarter, which was -6.10% lower than expectations of -$0.33.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 3 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPID is Buy with a score of 4.00. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.